Literature DB >> 1729344

Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center.

J W Deckers1, J M Hare, K L Baughman.   

Abstract

To determine the incidence, nature and subsequent management of complications occurring during right ventricular endomyocardial biopsy in patients with cardiomyopathy, all events occurring during 546 procedures in 464 consecutive patients were prospectively recorded. The internal jugular vein was the primary site of introduction in 96% of cases. A total of 33 complications (6%) occurred: 15 (2.7%) during catheter insertion including 12 arterial punctures (2%), 2 vasovagal reactions (0.4%) and 1 episode of prolonged bleeding (0.2%), all without sequelae; 18 (3.3%) during biopsy included 6 arrhythmias (1.1%), 5 conduction abnormalities (1%), 4 possible perforations (0.7%) and 3 definite perforations (0.5%) (pericardial fluid). Two (0.4%) of the three patients with a perforation died. There was no secular trend in the complication rate, nor were complications associated with specific clinical or hemodynamic characteristics. It is concluded that the overall rate of endomyocardial biopsy complications (6%) is low, but mortality may occur.

Entities:  

Mesh:

Year:  1992        PMID: 1729344     DOI: 10.1016/0735-1097(92)90049-s

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

3.  Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Authors:  Juyup Han; Yongwhi Park; Hyunsang Lee; Hyunjae Kang; Hyungseop Kim; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 4.  Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

5.  Focal myocarditis mimicking acute ST-elevation myocardial infarction: diagnosis using cardiac magnetic resonance imaging.

Authors:  Jeffrey M Testani; Daniel M Kolansky; Harold Litt; Edward P Gerstenfeld
Journal:  Tex Heart Inst J       Date:  2006

Review 6.  Cardiotoxicity of Immune Checkpoint Inhibitors.

Authors:  Lili Zhang; Maeve Jones-O'Connor; Magid Awadalla; Daniel A Zlotoff; Paaladinesh Thavendiranathan; John D Groarke; Alexandra-Chloe Villani; Alexander R Lyon; Tomas G Neilan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-06-08

7.  Diagnostic performance of cardiac magnetic resonance for the detection of acute cardiac allograft rejection: a systematic review and meta-analysis.

Authors:  Wei Lu; Jun Zheng; Xu-Dong Pan; Ming-Duo Zhang; Tie-Yuan Zhu; Bin Li; Li-Zhong Sun
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 8.  Updates on Heart Transplantation.

Authors:  Kevin S Shah; Michelle M Kittleson; Jon A Kobashigawa
Journal:  Curr Heart Fail Rep       Date:  2019-10

9.  Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy.

Authors:  Adriana Luk; Mohammed Metawee; Eric Ahn; F Gustafsson; Heather Ross; Jagdish Butany
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 10.  Non-invasive imaging in the diagnosis of acute viral myocarditis.

Authors:  Michael Jeserich; Stavros Konstantinides; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2009-09-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.